AroCell nomination committee for the AGM 2023

30 November 2022 - 17:18

AroCell AB (publ.) publishes the nomination committee’s composition for the AGM in 2023.

The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on May 24th, 2022, consists of the:

  • Clas Runnberg, represents Labbex Förvaltnings AB
  • Jon Eiken, represents his shares
  • Mikael Lönn, represents his shares

Before the annual general meeting 2023, the nomination committee shall prepare a proposal for the election of the chairman and other members of the board of directors, the election of the chairman of the annual meeting, the election of auditors, the determination of fees, and matters pertaining thereto.
For more information, please visit:
Nomination committee - AroCell
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting 2023 can e-mail [email protected] (header ”AroCell´s nomination committee”).
The proposals should be submitted to the nomination committee before January 31st, 2023.

Provided by: MFN
Nasdaq First North GM Stockholm (Sweden)
AroCell AB
AroCell is working in the area of cancer diagnostics. The Company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More